BioBox

Profile

BioBox builds the infrastructure that turns scientific judgment and reasoning into reproducible, scalable AI systems for drug discovery.

Pharmaceutical R&D depends on expert judgment that largely resides in individual scientists rather than in durable, reusable systems. High-stakes decisions, including target identification, indication selection, and portfolio strategy, require teams to reconcile conflicting evidence, assess uncertainty, and apply scientific rigor across complex datasets and organizational boundaries.

BioBox’s award-winning enterprise platform, DecisionOS, enables scientists to unify scientific evidence, encode expert judgment into transparent reasoning modules, and deploy those modules consistently across teams and programs. Rather than replacing scientific expertise, DecisionOS makes it explicit, reproducible, and scalable.

Already deployed across top 20 pharmaceutical companies, DecisionOS helps R&D organizations preserve institutional knowledge, standardize how critical decisions are made, and reduce the time and effort required to evaluate scientific opportunities. The result is faster, more consistent decision-making, better allocation of R&D resources, and institutional judgment that compounds across the drug discovery lifecycle.

Website

biobox.io

Contact


Event details

Date: October 7 - 9, 2026

Event contact

Stephen Ip
Senior International Market Consultant
Japan and Korea

Participants

13 in total